Abstract
Inhibition of platelet aggregation with eptifibatide reduced the incidence of the composite end point of death or nonfatal myocardial infarction in patients with acute coronary syndromes who did not have persistent ST-segment elevation.
Keywords
EptifibatideMedicinePlaceboInternal medicineAspirinMyocardial infarctionAcute coronary syndromePlateletCardiologyST segmentPlatelet aggregation inhibitorCreatine kinaseAnesthesiaPercutaneous coronary intervention
Affiliated Institutions
Related Publications
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
New strategies for profound inhibition of platelet activity at the injured coronary plaque focus on blockade of the platelet surface membrane glycoprotein IIb/IIIa receptor, whi...
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
When administered with heparin and aspirin, the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban was associated with a lower incidence of ischemic events in patients ...
Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease
Background —A proportion of patients who present with suspected acute coronary syndrome (ACS) are found to have insignificant coronary artery disease (CAD) during coronary angio...
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
Although parenteral therapy with glycoprotein (GP) IIb/IIIa inhibitors has resulted in a reduced risk of death or myocardial infarction in patients with acute coronary syndromes...
Stroke in Patients With Acute Coronary Syndromes
Background —The incidence of stroke in patients with acute coronary syndromes has not been clearly defined because few trials in this patient population have been large enough t...
Publication Info
- Year
- 1998
- Type
- article
- Volume
- 339
- Issue
- 7
- Pages
- 436-443
- Citations
- 1435
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1435
OpenAlex
Cite This
The PURSUIT trial investigators
(1998).
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes.
New England Journal of Medicine
, 339
(7)
, 436-443.
https://doi.org/10.1056/nejm199808133390704
Identifiers
- DOI
- 10.1056/nejm199808133390704